HBM Healthcare Investments AG

As of June 30, 2026, HBM Healthcare Investments AG carries a market capitalization of 1.59B, placing it among publicly traded companies globally. Its enterprise value stands at 1.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

HBM Healthcare Investments AG's next confirmed earnings release is scheduled for October 23, 2026.

As of June 30, 2026, HBM Healthcare Investments AG has 6.60M shares outstanding.

As of June 30, 2026, HBM Healthcare Investments AG trades at a trailing price-to-earnings ratio of 5.82. The price-to-sales ratio is 5.77, and the price-to-book ratio stands at 0.78.

These figures are as of June 30, 2026. The EV/Sales ratio of 6.05 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.68B versus a market cap of 1.59B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, HBM Healthcare Investments AG posted a return on equity (ROE) of 14.98, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 13.95, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 14.21, useful for judging operating efficiency across full business cycles. The company generates approximately 7.92M in revenue per employee across its workforce of 35.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, HBM Healthcare Investments AG's stock has gained approximately 14.96% over the past 52 weeks.

Over the twelve months ended June 30, 2026, HBM Healthcare Investments AG generated 277.05M in revenue and converted that into 274.55M in net income, yielding earnings per share of 41.30.

As of June 30, 2026, HBM Healthcare Investments AG holds 8.29M in cash and equivalents against 99.81M in total debt, resulting in a net debt position of -8.28M.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, HBM Healthcare Investments AG paid dividends of 8.83 per share. The dividend payout ratio of 21.38 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 1.26, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to HBM Healthcare Investments AG shareholders.